This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 11

Based on the information you provided, we found the following studies.

  • A Phase 1/2 Study of Nivolumab (IND#124729) in Children, Adolescents, and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab. Study goals: find highest safe dose of nivolumab without causing severe side effects; learn side effects nivolumab causes;learn how your body handles nivolumab;learn the effects of nivolumab on cells and proteins in blood and tumor tissue;see if nivolumab is a beneficial treatment for your tumor. This study is researching all of the following topics: Cancerous bone tumor, Osteosarcoma Hodgkin's lymphoma Melanoma NB, Neuroblastoma Non-Hodgkin's lymphoma Rhabdomyosarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
  • A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial T cells, a type of white blood cell, will be collected by a procedure called leukapheresis and used to evaluate cell collection and processing procedures and learn how these cells could potentially be used in the future to treat a variety of cancers that involve B cells (a type of white blood cell). This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) CLL ( Chronic lymphocytic leukemia) Hodgkin's lymphoma Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II Study Of DCDT2980S and Rituximab Relapsed Or DCDS4501A and Rituximab in Refractory B-Cell Non-Hodgkin's Lymphoma Study purpose: test 2 experimental drugs, DCDT2980S and DCDS4501A, in combination with rituximab or obinutuzumab, in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma to find out what effects, good and/or bad, these drugs have on you and your cancer. This study is researching all of the following topics: Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB050465 Monotherapy and in Combination With INCB039110 in Subjects With Previously Treated B-Cell Malignancies Study goals: determine how safe and well tolerated INCB050465 is alone and in combination with INCB039110 in subjects with types of leukemia or B cell blood cancers; study how they are broken down in the body, are eliminated from the body, and the effects that these drugs may have on your disease. This study is researching all of the following topics: CLL ( Chronic lymphocytic leukemia) Hodgkin's lymphoma Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase 1 Dose Escalation w/Two Disease Specific Expansions, Open-Label, Safety, Pharmacokinetic and Pharmacodynamic Study of APTO-253 in Patients with Relapsed or Refractory Hematologic Malignancies Study Purpose: test the safety of APTO-253; find the maximum dose of APTO-253 which can be tolerated when given two times a week; find out what effects, good and/or bad, this treatment has on you and your cancer and how APTO-253 may work in the body and your body's ability to get rid of APTO-253. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) Hodgkin's lymphoma Leukemia Lymphoma MDS ( Myelodysplastic syndrome ) Multiple myeloma Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Pharmacokinetics of Oral Alisertib (MLN8237) in Adult Patients with Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function The study purpose is to find out if liver health affects the body’s drug levels of experimental drug alisertib when taken by patients with cancer, and see if subjects with abnormal liver function have different side effects compared to subjects with normal liver function who take alisertib. This study is researching all of the following topics: Bladder cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer HCC, Liver cancer Hodgkin's lymphoma Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma Melanoma Non-Hodgkin's lymphoma Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1 Trial of SGN-CD70A in Patients with CD70-Positive Malignancies Investigational drug SGN-CD70A is being studied to evaluate the side effects of SCN-CD70A and what dose is safe.This study will evaluate how SGN-CD70A works against renal cell carcinoma (RCC) (kidney cancer) or non-Hodgkin’s lymphoma (NHL).This is the first time SGN-CD70A will be given to people. This study is researching all of the following topics: Kidney Cancer ( Malignant tumor of kidney ) Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial. This clinical research study will collect T cells, a type of white blood cell, through a procedure called leukapheresis.These cells will be used to evaluate cell collection and processing procedures, and learn how these cells could potentially be used in the future to treat a variety of cancers. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) CLL ( Chronic lymphocytic leukemia) Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 2 years old
  • Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and Graft-versus-host Disease in Allogeneic Hematopoietic Cell Transplantation for High-risk Hematologic Malignancies Investigational drug carfilzomib will be added to a standard chemotherapy conditioning regimen for donor blood stem cell transplant to test if this new conditioning regimen can lead to safe and more effective stem cell transplant treatment approach for patients with quickly worsening blood cancers. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) Amyloidosis CLL ( Chronic lymphocytic leukemia) Leukemia Lymphoma MDS ( Myelodysplastic syndrome ) Multiple myeloma Myelofibrosis Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
    • Less than 66 years old
  • A Phase 1/2 Dose Escalation Safety, Pharmacokinetic and Efficacy Study of Multiple IV Administrations of SAR650984 Against CD38 In Patients with Selected CD38+ Hematological Malignancies The main purpose of this study is to evaluate the possible risks and the effectiveness of investigational drug SAR650984 in patients with multiple myeloma. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) CLL ( Chronic lymphocytic leukemia) Multiple myeloma Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
Showing 1-10 of 11 studies
Show more studies